主动脉球囊阻断技术与中低温停循环顺行脑灌注在急性A型主动脉夹层全弓置换加冰冻象鼻术中的比较
本研究回顾性比较了急性A型主动脉夹层行全弓置换加冰冻象鼻术中,采用主动脉球囊阻断技术(ABO,79例)与中低温停循环联合顺行脑灌注(MHCA/ACP,109例)的疗效。结果显示ABO组停循环时间显著缩短(4.8±1.2分钟 vs 18.4±3.1分钟,P<.001),复合终点事件相当,但ABO组高级别急性肾损伤和肝功能障碍发生率更低。
要点
- ABO技术显著缩短全弓置换加冰冻象鼻术中的停循环时间。
- ABO组高级别急性肾损伤和肝功能障碍发生率低于MHCA/ACP组。
- ABO技术对通气时间>24小时、肝功能障碍和II-III级急性肾损伤具有保护作用。
核心结论
- ABO技术在全弓置换加冰冻象鼻术中显著缩短停循环时间,并对肝肾功能有一定保护作用。
研究设计与样本
- 回顾性研究,纳入急性A型主动脉夹层行全弓置换加冰冻象鼻术的患者,ABO组79例,MHCA/ACP组109例。
主要发现
- ABO组停循环时间平均4.8±1.2分钟,MHCA/ACP组平均18.4±3.1分钟,P<.001。
- 复合终点事件ABO组11.4%,MHCA/ACP组13.8%,P=.631。
- ABO组高级别急性肾损伤发生率22.8%,MHCA/ACP组36.7%,P=.041。
- ABO组肝功能障碍发生率11.4%,MHCA/ACP组28.4%,P=.005。
关键数值与推荐
- 多因素logistic分析显示ABO技术对通气时间>24小时具有保护作用(OR 0.455,95%CI 0.234-0.887,P=.021)。
- ABO技术对肝功能障碍具有保护作用(OR 0.218,95%CI 0.084-0.561,P=.002)。
- ABO技术对II-III级急性肾损伤具有保护作用(OR 0.432,95%CI 0.204-0.915,P=.028)。
临床怎么用
- 在急性A型主动脉夹层全弓置换加冰冻象鼻术中,可考虑采用ABO技术以缩短停循环时间并减少肝肾功能损伤。
局限性
- 需要未来大样本研究以全面评估该新技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Moderate hypothermic circulatory arrest (MHCA) with antegrade cerebral perfusion (ACP) is safe and efficient in total arch replacement (TAR) and frozen elephant trunk (FET) for acute type A aortic dissection (ATAAD). Complications related to hypothermia and ischemia are inevitable, however. The aortic balloon occlusion (ABO) technique is performed to elevate the lowest nasopharyngeal temperature to 28°C and shorten the circulatory arrest time. In this study, we aimed to evaluate the efficacy of this new technique. METHODS: We reviewed the clinical data of patients with ATAAD who underwent TAR and FET, including 79 who underwent ABO and 109 who underwent MHCA/ACP. RESULTS: Circulatory arrest time was significantly lower in the ABO group compared with the MHCA/ACP group (mean, 4.8 ± 1.2 minutes vs 18.4 ± 3.1 minutes; P < .001). The composite endpoint was comparable in the 2 groups (11.4% for ABO vs 13.8% for MHCA/ACP; P = .631). Fewer patients in the ABO group developed high-grade acute kidney injury (AKI) according to a modified RIFLE criterion (22.8% vs 36.7%; P = .041), and the rate of hepatic dysfunction was lower in the ABO group (11.4% vs 28.4%; P = .005). Multivariable logistic analysis showed that the ABO technique is protective against duration of ventilation >24 hours (odds ratio [OR], 0.455; 95% confidence interval [CI], 0.234-0.887; P = .021), hepatic dysfunction (OR, 0.218; 95% CI, 0.084-0.561; P = .002), and grade II-III AKI (OR, 0.432; 95% CI, 0.204-0.915; P = .028). CONCLUSIONS: The ABO technique significantly shortens the circulatory arrest time in TAR and FET. Available clinical data suggest that it has a certain protective effect on the liver and kidney. Future large-sample studies are warranted to thoroughly evaluate this new technique.
引用
- Liu Y, Shi Y, Guo H, et al. Aortic balloon occlusion technique versus moderate hypothermic circulatory arrest with antegrade cerebral perfusion in total arch replacement and frozen elephant trunk for acute type A aortic dissection. J Thorac Cardiovasc Surg. 2019. PMID: 32169371. doi:10.1016/j.jtcvs.2019.08.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。